China Market Research Reports & Industry Analysis

Publications found: 17,944

Sort by:

Survey of Electronic Hydrogen Fluoride in China

US$ 3,564.00

Electronic hydrogen fluoride is one of the indispensable key materials in solar photovoltaic, flat panel display and semiconductor manufacturing process. China's electronic hydrogen fluoride industry...

June 2021 27 pages

Investigation Report on China's Recombinant human thrombopoietin (rhTPO) Market 2021-2025

US$ 2,600.00

... with thrombopenia increases in China, the demand for Recombinant Human Thrombopoietin will also increase. Considering the high growth rate of the Recombinant Human Thrombopoietin market, Recombinant Human Thrombopoietin products by other ...

June 2021 50 pages

Investigation Report on China's Acetylcysteine Market 2021-2025

US$ 2,600.00

Acetylcysteine, also known as N-acetylcysteine (NAC), is a medication that is used to treat paracetamol (acetaminophen) overdose, and to loosen thick mucus in individuals with chronic bronchopulmonary...

June 2021 50 pages

Investigation Report on China's Anlotinib Market 2021-2025

US$ 2,600.00

Anlotinib is an oral multi-targeting small-molecule tyrosine kinase inhibitor that can target multiple angiogenic factor receptors to inhibit tumor angiogenesis. It can be used for advanced non-small...

June 2021 50 pages

Investigation Report on China's Dexmedetomidine Market 2021-2025

US$ 2,600.00

Dexmedetomidine is a highly selective ?2-adrenergic receptor agonist. It is mainly used clinically for the sedation of tracheal intubation and mechanical ventilation in surgical patients undergoing ge...

June 2021 50 pages

Investigation Report on China's Doxorubicin Market 2021-2025

US$ 2,600.00

Doxorubicin belongs to the anthracycline class (Anthracycline) antibiotics, which can inhibit the synthesis of RNA and DNA. It has a strong inhibitory effect on RNA and has a broad anti-tumor spectrum...

June 2021 50 pages

Investigation Report on China's Emtricitabine/Tenofovir Market 2021-2025

US$ 2,600.00

Emtricitabine/Tenofovir is the first HIV drug approved for prophylaxis. It was developed by Gilead Sciences Inc (the original drug is called TRUVADA). Its product was first approved in the United Stat...

June 2021 50 pages

Investigation Report on China's Enteral Nutrition Market 2021-2025

US$ 2,600.00

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness and malnutrition. It was d...

June 2021 50 pages

Investigation Report on China's Express Delivery Industry 2021-2025

US$ 2,600.00

Express delivery is a door-to-door logistics activity with postal functions, which means express companies use rail, road, and air transportation to quickly deliver customers' goods. According to CRI’...

June 2021 50 pages

Investigation Report on China's Goserelin Market 2021-2025

US$ 2,600.00

Goserelin is a synthetic analogue of a naturally occurring gonadotropin-releasing hormone (GnRH). Goserelin is developed by AstraZeneca, is mainly used to treat advanced breast and prostate cancer. In...

June 2021 50 pages

Investigation Report on China's Hydrotalcite Market, 2021-2025

US$ 2,600.00

Hydrotalcite is suitable for acute and chronic gastritis, reflux esophagitis, gastric and duodenal ulcers, stomach pain, heartburn, acid belching, fullness and other uncomfortable symptoms related to...

June 2021 50 pages

Investigation Report on China's Insulin Glargine Market 2021-2025

US$ 2,600.00

Insulin Glargine is a long-acting human insulin analog that can control the patient's blood sugar more effectively and steadily. It is often used to treat type 1 and type 2 diabetes. Its original rese...

June 2021 50 pages

Investigation Report on China's Leuprorelin Market 2021-2025

US$ 2,600.00

Leuprolide is a synthetic gonadotropin drug used to treat hormone-responsive cancers such as prostate cancer and breast cancer. It can also be used to treat precocious puberty and prevent premature ov...

June 2021 50 pages

Investigation Report on China's Levofloxacin Market 2021-2025

US$ 2,600.00

Levofloxacin, developed by Daiichi Sankyo, is used to treat bacterial infectious diseases such as community pneumonia, sinusitis, urinary tract infections. Levofloxacin tablets were approved in China...

June 2021 50 pages

Investigation Report on China's Moxifloxacin Market 2021-2025

US$ 2,600.00

Moxifloxacin is a fourth-generation synthetic quinolone antibacterial drug (8-methoxy-fluoroquinolone antibiotic) developed by Bayer Vital GmbH. It was approved for marketing by the FDA in December 19...

June 2021 50 pages

Investigation Report on Global and China's MOSFET Market 2021-2025

US$ 2,600.00

MOSFET is an acronym for Metal Oxide Semiconductor Field Effect Transistor, also known as MOS, MOS transistor. The name 'metal–oxide–semiconductor' (MOS) typically refers to a type of insulated-gate f...

June 2021 50 pages

Investigation Report on China's Daratumumab Market 2021-2025

US$ 2,600.00

Daratumumab, developed by Johnson & Johnson, is a monoclonal antibody available for the treatment of myeloma. Its product DARZALEX was approved for the treatment of patients with multiple myeloma who...

June 2021 50 pages

Investigation Report on China's Docetaxel Market 2021-2025

US$ 2,600.00

Docetaxel, sold under the brand name Taxotere, is a paclitaxel anti-tumor drug used for the treatment of locally advanced or metastatic non-small cell lung cancer. Docetaxel injection was first develo...

June 2021 50 pages

Investigation Report on China's Liraglutide Market 2021-2025

US$ 2,600.00

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, developed by Novo Nordisk A/S. Its product VICTOZA firstly launched in the EU in July 2009 and firstly approved to enter the Chinese...

June 2021 50 pages

Investigation Report on China's Omalizumab Market 2021-2025

US$ 2,600.00

Omalizumab, developed by Novartis Europharm, is the only approved antibody designed to target and block immunoglobulin E (IgE). At the end of 2017, the FDA approved the registration of Novartis Europh...

June 2021 50 pages

Investigation Report on China's Oxaliplatin Market 2021-2025

US$ 2,600.00

Oxaliplatin (OXA) is the third-generation platinum anti-tumor drug after cisplatin and carboplatin. Oxaliplatin was jointly developed by Sanofi and Debiopharm for the first-line treatment of metastati...

June 2021 50 pages

Investigation Report on China's Pantoprazole Market 2021-2025

US$ 2,600.00

Pantoprazole is the third proton pump inhibitor marketed globally. Compared with omeprazole, it has higher selectivity and bioavailability. Pantoprazole is more stable than omeprazole and lansola unde...

June 2021 50 pages

Investigation Report on China's Pertuzumab Market 2021-2025

US$ 2,600.00

Pertuzumab is the first monoclonal antibody called 'HER dimerization inhibitor'. It mainly used to treat HER2-positive breast cancer. It was developed by Genentech, a subsidiary of Roche Pharma (Schwe...

June 2021 50 pages

Investigation Report on China's Rabeprazole Market 2021-2025

US$ 2,600.00

Rabeprazole is a kind of proton pump inhibitor (PPI) gastric acid inhibitor. It is used for the treatment of gastroesophageal reflux disease and maintenance treatment after recovery. It is also suitab...

June 2021 50 pages

Investigation Report on China's Ruxolitinib Market 2021-2025

US$ 2,600.00

Ruxolitinib was developed by Novartis Pharma Schweiz AG. It is an orally bioavailable Janus-associated kinase (JAK) inhibitor with selectivity for subtypes JAK1 and JAK2. Its product is used for the t...

June 2021 50 pages

Investigation Report on China's Sitagliptin Market 2021-2025

US$ 2,600.00

Sitagliptin is the world's first listed oral dipeptidyl peptidase-4 (DPP-4) inhibitor, developed by Merck Sharp & Dohme Ltd (JANUVIA). It was approved by the U.S. FDA in October 2006 to be used as a s...

June 2021 50 pages

Packaged Water in China - Market Summary, Competitive Analysis and Forecast to 2024

US$ 350.00

Packaged Water in China - Market , Competitive Analysis and Forecast to 2024 SUMMARY Packaged Water in China industry profile provides top-line qualitative and quantitative summary information includi...

June 2021 38 pages

Market Research of Aspartame in China

US$ 4,104.00

China officially approved the application of aspartame in foods and beverages in 1986. After years of development, China has become the world's largest producer of aspartame. The production of aspart...

June 2021 18 pages

Corn Products China News 2104

US$ 3,564.00

... the price. Several corn further processing programs are being launched. Zhonglang Biology's 300,000 t/a corn starch program and Youyi Longliang's logistics and corn deep-processing project are ...

June 2021 34 pages

China Organic Food Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Financial Insight

US$ 2,290.00

It's no wonder that China has become a gold mine for organic food producers from all over the world, given its enormous potential. Organic food is the fastest-growing market in Asia-Pacific’s region a...

June 2021 110 pages

China Li-ion Battery E-News 2105

US$ 2,484.00

... and 16.66% MoM. Lithium carbonate saw a price slump in August due to weak demand and supply growth, resulting in a markdown on cathode materials. China Li-ion Battery E-News is a monthly published ...

May 2021 28 pages

Fungicides China News 202101

US$ 3,564.00

... on the entire fungicide industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production ...

May 2021 37 pages

Insecticides China News 202101

US$ 3,564.00

... insecticide industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production ... pests in some areas. Multiple organophosphorus insecticides ... company itself, production ... insecticides, with the quantity of registrations ...

May 2021 35 pages

Seed China News 202101

US$ 1,080.00

... diseases may strike China in 2019, damaging seed production this year. Seed China News is a monthly ... corn purchases under price declines. This is aimed at stabilising the domestic corn market. China's corn ... product mix and capacity. In 2018, China's corn varieties were characterised by 1) increased number for ...

May 2021 48 pages

Investigation Report on China's Abiraterone Market 2021-2025

US$ 2,600.00

Abiraterone is a CYP17 inhibitor, which is mainly clinically used to treat prostate cancer patients. Its product ZYTIGA was developed by Janssen-Cilag International NV(a subsidiary of Johnson & Johnso...

May 2021 50 pages

Investigation Report on China's Butylphthalide Market 2021-2025

US$ 2,600.00

Butylphthalide, developed by CSPC Enbipu Pharmaceutical Co. Ltd is used to treat mild to moderate acute ischemic stroke. Its soft capsule was approved in China in 2005, and its injection was approved...

May 2021 50 pages

Investigation Report on China's Dasatinib Market 2021-2025

US$ 2,600.00

Dasatinib, developed by Bristol-Myers Squibb, is an anti-tumor drug. It was first approved by the FDA in 2006 for the treatment of adult patients with Philadelphia chromosome-positive (Ph+) chronic my...

May 2021 50 pages

Investigation Report on China's Dolutegravir Market 2021-2025

US$ 2,600.00

Dolutegravir was developed by GlaxoSmithKline for the treatment of HIV-infected adults and children over 12 years old. Its product TIVICAY was approved in China in 2016 and was approved for children's...

May 2021 50 pages

Investigation Report on China's Esomeprazole Market 2021-2025

US$ 2,600.00

Esomeprazole is a proton pump inhibitor (PPI), which can effectively inhibit gastric acid secretion. It is clinically used to treat gastric acid-related diseases such as gastroesophageal reflux diseas...

May 2021 50 pages

Investigation Report on China's Golimumab Market 2021-2025

US$ 2,600.00

Golimumab is an immunosuppressive medication that can effectively regulate inflammation and bone metabolism. The trade name of Golimumab is SIMPONI, which was developed by Janssen Biologics BV. Its pr...

May 2021 50 pages

Investigation Report on China's Paclitaxel Market 2021-2025

US$ 2,600.00

Paclitaxel is a chemotherapeutic tumor drug used to treat metastatic breast cancer after failure of combination chemotherapy or relapse within 6 months after adjuvant chemotherapy. Its product, develo...

May 2021 50 pages

Investigation Report on China's Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) 2021-2025

US$ 2,600.00

Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) is an effective drug for the prevention and treatment of neutropenia or deficiency caused by tumor radiotherapy or chemo...

May 2021 50 pages

Investigation Report on China's Piperacillin and Tazobactam Market 2021-2025

US$ 2,600.00

Piperacillin and Tazobactam is a compound anti-infective drug composed of piperacillin (semi-synthetic penicillin antibiotic) and tazobactam (?-lactamase inhibitor). It is suitable for moderate and se...

May 2021 50 pages

Investigation Report on China's Propofol Market 2021-2025

US$ 2,600.00

Propofol is a short-acting intravenous anesthetic. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. It is als...

May 2021 50 pages

Investigation Report on China's Tiotropium Bromide Market 2021-2025

US$ 2,600.00

Tiotropium Bromide, developed by Boehringer Ingelheim International GmbH, is used to treat chronic obstructive pulmonary disease (COPD). Its product SPIRIVA was approved in China in 2006. In 2017, Tio...

May 2021 50 pages

Investigation Report on China's Tocilizumab Market 2021-2025

US$ 2,600.00

The trade name of Tocilizumab is ACTEMRA, which was developed by Roche Pharma (Schweiz) AG. In 2013, its product was firstly approved in China and its indication is RA. Tocilizumab was approved in Chi...

May 2021 50 pages

Investigation Report on China's Voriconazole Market 2021-2025

US$ 2,600.00

Voriconazole is used to treat progressive, potentially life-threatening fungal infections. Its product was developed by Pfizer. It was approved in China in 2004. By 2020, there are 11 manufacturers of...

May 2021 50 pages

Investigation Report on Chinese Compound Amino Acid Market 2021-2025

US$ 2,600.00

Compound Amino Acid is clinically used for patients with insufficient protein intake, malabsorption, and other amino acids that cannot meet the requirements of body metabolism. It was developed by Jap...

May 2021 50 pages

Residential Construction in China - Market Summary, Competitive Analysis and Forecast to 2025

US$ 350.00

Residential Construction in China - Market @, Competitive Analysis and Forecast to 2025 SUMMARY Residential Construction in China industry profile provides top-line qualitative and quantitative summar...

May 2021 39 pages

Telecommunication Services in China - Market Summary, Competitive Analysis and Forecast to 2025

US$ 350.00

Telecommunication Services in China - Market @, Competitive Analysis and Forecast to 2025 SUMMARY Telecommunication Services in China industry profile provides top-line qualitative and quantitative su...

May 2021 40 pages

Filters

Clear all